Through the bioinformatics analysis (DEG analysis and GO and KEGG pathway enrichment analysis) of disease signature (Figure 6D), we found that CDKN1A, a cell cycle regulator, is up-regulated, and the cell cycle pathway is enhanced in lung cancer patients. This evidence concerns the gene CDKN1A and lung carcinoma.